Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Crossref DOI link: https://doi.org/10.1186/s12879-017-2573-8
Published Online: 2017-07-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ou, Huang-Tz
Lee, Tsung-Ying
Chen, Yee-Chun
Charbonneau, Claudie
Funding for this research was provided by:
Pfizer UK